Preferred Label : Human papilloma virus 16 & 18 45 E6 E7 mRNA:Prid:Pt:Cvx:Nom:Probe.amp.tar;
LOINC status : ACTIVE;
LOINC display name : HPV 16 and 18 45 E6 E7 mRNA NAA probe Nom (Cvx);
LOINC long common name : Human papilloma virus 16 and 18 45 E6 E7 mRNA [Identifier] in Cervix by NAA with probe
detection;
LOINC short name : HPV16 18 45 E6 E7mRNA Cvx NAA probe;
LOINC description : Detects E6/E7 viral messenger RNA (mRNA) of human papillomavirus (HPV) types 16, 18,
and 45 in cervical specimens from women with positive HPV assay results. For women
21-years and older with atypical squamous cells of undetermined significance (ASC-US)
cervical cytology results, and HPV positive assay results, this assay can be used
to assess the presence or absence of high-risk HPV genotypes 16, 18, and/or 45. For
women 30-years and older, the HPV 16, 18, and/or 45 genotype assay can be used to
test samples from women with HPV assay positive results, along with cervical cytology
results. This assay has not been evaluated for HPV vaccinated patients or in cases
of suspected abuse. It differentiates HPV 16 from HPV 18 and/or HPV 45, but does not
differentiate HPV 18 and HPV 45. This term was created for, but not limited in use
to, the Aptima HPV 16 18/45 genotype assay which uses target capture, target amplification
by transcription-mediated amplification and detection of the amplification products
by hybridization protection assay (HPA).;
Origin ID : 82354-2;
UMLS CUI : C4298767;
Has component
- Has method
- Has property
- Has scale
- Has system
- Has time aspect
- Part of panel
- Semantic type(s)
